Journal of the American Society of Hypertension
Volume 2, Issue 5 , Pages 355-365.e2 , September 2008

Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death

  • Patricia R. Hebert, PhD

      Affiliations

    • Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    • ,
  • Christopher S. Coffey, PhD

      Affiliations

    • Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, USA
    • ,
  • Daniel W. Byrne, MS

      Affiliations

    • Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • ,
  • Theresa A. Scott, MS

      Affiliations

    • Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • ,
  • Robert H. Fagard, MD, PhD

      Affiliations

    • Hypertension and Cardiovascular Rehabilitation Unit, University of Leuven K. U. Leuven, Leuven, Belgium
    • ,
  • Jeffrey N. Rottman, MD

      Affiliations

    • Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • Division of Cardiovascular Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • ,
  • Katherine T. Murray, MD

      Affiliations

    • Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • Division of Cardiovascular Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • ,
  • John A. Oates, MD

      Affiliations

    • Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
    • Corresponding Author InformationCorresponding author: John A. Oates, MD, Vanderbilt Medical Center, 536 RRB, Nashville, Tennessee 37232. Tel: 615-343-4847; fax: 615-322-5303

Received 22 February 2008 ,Accepted 1 April 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported, in part, by a grant from the National Institute of General Medical Sciences (GM 15431). Dr. Oates is the Thomas F. Frist, Sr. Professor of Medicine and is a consultant for Merck. Supplemental Material is available at www.ashjournal.com.

PII: S1933-1711(08)00046-6

doi: 10.1016/j.jash.2008.04.001

Journal of the American Society of Hypertension
Volume 2, Issue 5 , Pages 355-365.e2 , September 2008

Article Tools

* Image Usage & Resolution